This webinar provides an overview of the current landscape, areas of growth and investment, where to find training opportunities and the types of careers available across a broad spectrum of technologies including complex therapies, advanced manufacturing, data driven drug discovery and more.

UK biotech is on a robust upward trajectory this year, raising a total of £563 million in venture capital and public financings during the three months leading up to September.

Leading figures and experts in the UK biotech and life science sector discuss the threats and opportunities of the Inflation Reduction Act to the sector.

The Chancellor’s Autumn Statement announced a proposed cut to the rate of the SME R&D tax relief scheme, effectively halving its value for loss-making companies.